ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

CNTX Context Therapeutics Inc

1.81
-0.15 (-7.65%)
17 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Context Therapeutics Inc CNTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.15 -7.65% 1.81 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.97 1.92 2.02 1.94 1.96
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/6/202406:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202406:34EDGAR2Form 8-K - Current report
02/6/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
31/5/202415:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/5/202415:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
24/5/202406:31EDGAR2Form S-3 - Registration statement under Securities Act of..
10/5/202415:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/5/202415:06GLOBEContext Therapeutics Reports First Quarter 2024 Operating..
08/5/202415:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/5/202406:31GLOBEContext Therapeutics Announces FDA Clearance of IND..
02/5/202406:30GLOBEContext Therapeutics Announces $100 Million Private..
01/4/202406:30GLOBEContext Therapeutics Submits IND Application to Evaluate..
21/3/202406:43GLOBEContext Therapeutics Reports Full Year 2023 Operating and..
06/3/202406:30EDGAR2Form 8-K - Current report
07/2/202415:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/11/202315:15GLOBEContext Therapeutics Reports Third Quarter 2023 Operating..
09/11/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202308:04EDGAR2Form 8-K - Current report
31/10/202308:00GLOBEContext Therapeutics Announces Preclinical Data..
27/9/202308:00GLOBEContext Therapeutics Announces Acceptance of Abstract to be..
09/8/202315:10GLOBEContext Therapeutics Reports Second Quarter 2023 Operating..
09/8/202315:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202307:11EDGAR2Form 8-K - Current report
01/8/202306:30GLOBEContext Therapeutics to Participate in Two August 2023..

Su Consulta Reciente

Delayed Upgrade Clock